Form 4: Atlas Venture Opportunity Fund II, L.P. Reduces Stake in Korro Bio, Inc. (KRRO)

Atlas Venture Opportunity Fund II, L.P. reports a disposition of Korro Bio, Inc. shares, decreasing its holdings.

Summary

• On April 22, 2024, Atlas Venture Opportunity Fund II, L.P. disposed of 17,857 shares of Korro Bio, Inc. common stock at a price of $56 per share.
• Following the transaction, the fund's beneficial ownership decreased to 195,074 shares.
• The reporting entities include Atlas Venture Associates Opportunity II, L.P. and Atlas Venture Associates Opportunity II, LLC, which serve as general partners to Atlas Venture Opportunity Fund II, L.P.
• These entities disclaim beneficial ownership except to the extent of their pecuniary interest.

Sentiment

Score: 5

Explanation: Neutral sentiment as it reports a transaction without expressing a positive or negative outlook.

Negatives

• Atlas Venture Opportunity Fund II, L.P. reduced its stake in Korro Bio, Inc.

Industry Context

This transaction reflects changes in investment positions within the biotechnology sector, which is subject to volatility based on clinical trial outcomes, regulatory approvals, and market conditions.

Comparison to Industry Standards

• Form 4 filings are standard practice for reporting changes in beneficial ownership by insiders and major shareholders.
• Similar transactions are routinely observed across the biotechnology industry, with investment firms adjusting their positions based on portfolio strategies and company performance.
• Comparing the size and frequency of these transactions to those of other major shareholders in Korro Bio and similar companies could provide further insights into market sentiment.

Stakeholder Impact

• The reduction in stake by a major shareholder like Atlas Venture could potentially influence investor sentiment regarding Korro Bio, Inc.

Key Dates